COPD

Emphysema treatment meets key endpoints in phase 2 study
Efdoralprin alfa is aimed at treating adults with alpha-1 antitrypsin deficiency emphysema.
October 30, 2025
Clinical Trial
Hypnosis could ease anxiety about ventilation masks
Pilot study shows it can help patients with COPD and other lung diseases.
October 30, 2025
Mask
Global burden of COPD expected to increase through 2050
COPD exacerbations and associated costs are expected to skyrocket in the next 25 years.
October 22, 2025
Global Burden
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2025 to 2034.
April 10, 2025
Pulmonary drug market forecast
Discovery may unlock regenerative therapies for lung disease
A molecular “switch” in the lungs helps to repair tissue and fight infection.
October 22, 2025
Lung Treatment
Online music program boosts quality of life for people with COPD, ILD
The approach helps patients overcome obstacles to conventional pulmonary rehabilitation alone.
October 15, 2025
Getty Images 653495212
Pirfenidone shows promise for COPD patients
Research shows the drug does more than treat pulmonary fibrosis.
October 15, 2025
Getty Images 1173676757
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
COPD, asthma inhalers drive greenhouse gas emissions
October 8, 2025
Inhaler
Changes could boost access to noninvasive ventilation for COPD
Efforts led by the American College of Chest Physicians helped lead to proposed changes in the federal coverage guidelines.
October 8, 2025
Noninvasive Ventilation
Researchers pioneer new breathing test for lung disease
The test could detect COPD and asthma earlier, more accurately and closer to home.
October 2, 2025
A volunteer undertaking a computed cardiopulmonography based breath test.
Sponsored
CDC respiratory virus guidance
Ascend Media
Review recommendations and updates to help prevent illness.
April 10, 2025
CDC respiratory virus guidance
Treatment helps rhinovirus infections in COPD patients
Vapendavir showed beneficial results in rhinovirus challenge study.
October 2, 2025
Altesa BioSciences is hoping that its rhinovirus treatment vapendavir can disrupt the cycle of the virus in COPD patients.
Carbon dioxide may drive lung damage in COPD
Elevated levels of CO2 may play a bigger role in COPD than previously thought.
September 25, 2025
Carbon Dioxide
Benralizumab misses endpoint in COPD trial
The drug fell short of expectations in the RESOLUTE phase 3 trial.
September 25, 2025
Clinical Trial1
Page 1 of 18
Next Page
Most Popular
Pirfenidone shows promise for COPD patients
Global burden of COPD expected to increase through 2050
Fresh insight on chronic lung transplant rejection
New digital tools empower children in asthma care decisions
Scientists discover key biomarker in asthma via ferroptosis pathway
Scientists propose ‘small lung syndrome’ category